IE 11 is not supported. For an optimal experience visit our site on another browser.

Cancer drug to get quick review

Sonus Pharmaceuticals Inc. said U.S. regulators would accelerate their review of the company’s experimental cancer drug, a more convenient version of the widely used treatment Taxol.
/ Source: The Associated Press

Sonus Pharmaceuticals Inc. said on Wednesday U.S. regulators would accelerate their review of the company’s experimental cancer drug, a more convenient version of the widely used treatment Taxol.

SONUS IS testing its version of the drug for a range of cancers. The U.S. Food and Drug Administration granted the “fast-track” review for a category of cancers that includes bladder cancer.

Fast-track review allows the agency to start reviewing data from clinical trials of a drug before the entire marketing application is complete.

© 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters.